cholesterol 24S-hydroxylase inhibitor

cholesterol 24S-hydroxylase inhibitor
Trade Name
Orphan Indication Dravet Syndrome
USA Market Approval USA
USA Designation Date 2017-11-29 00:00:00
Sponsor Takeda Development Center Americas, Inc.;Takeda Parkway;Deerfield, Illinois, 60015
Related Access Program
M. Scott Perry – Dravet Syndrome M. Scott Perry – Dravet Syndrome University of Colorado, Denver – Dravet Syndrome Children’s Hospital Medical Center, Cincinnati – Dravet Syndrome